Irvine-based Helio Genomics announces partnership with Quest Diagnostics to distribute its liver cancer detection test HelioLiver.
Fierce Healthcare: Quest Diagnostics' new transplant support services aim to expedite test results, offer at-home lab draws
Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...
Quest Diagnostics' new transplant support services aim to expedite test results, offer at-home lab draws
Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...
Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. Developed by Fujirebio, the Lumipulse G test measures ...
Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more frequent screenings using technology developed at the MD Anderson Cancer Center ...
Yahoo Finance: Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease
MSN: Quest Diagnostics (DGX) Develops MCaST Blood Test with MD Anderson Cancer Center
Quest Diagnostics (DGX) Develops MCaST Blood Test with MD Anderson Cancer Center
Seeking Alpha: Quest Diagnostics set to launch a rapid lab test to detect avian influenza A H5 virus
Quest Diagnostics (NYSE:DGX) announced on Wednesday that it will roll out a rapid molecular lab test to detect the avian influenza A H5 virus. This initiative is part of an award from the U.S. Centers ...